Background: Breast cancer ranks as the most frequent cancer among women. Detecting it early can lessen the disease's severe outcomes and death rates. Sonoelastography has proven effective in identifying breast cancer at an early stage. Objective: This article aimed to assess how well sonoelastography distinguishes between benign and malignant solid tumors in the breast. Material and methods: Medline resources (including PubMed, Medscape, ScienceDirect, EMF-Portal) and all available online materials up to 2023 for Sonoelastography and Solid breast lesions (Malignant and benign). Studies not meeting the inclusion criteria were excluded. The quality assessment of studies considered factors like obtaining ethical approval, specifying eligibility criteria, having appropriate controls, and providing sufficient information and defined assessment measures. Conclusion: Ultrasound elastography plays an important complementary role alongside traditional mammograms and ultrasounds in identifying solid breast lesions. Thus, this technique could aid in planning biopsies for lesions and preventing unnecessary procedures.